Pyridopyrazines and the use thereof as kinase inhibitors

Details Pyridopyrazines and the use thereof as kinase inhibitors Pyridopyrazines and the use thereof as kinase inhibitors

2008-01-29

2008-01-29

Tucker, Zachary C (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S117000, C544S350000

Reexamination Certificate

active

07323468

ABSTRACT:
The invention relates to novel pyrido[2,3-b]pyrazine derivatives of the general Formula I, their preparation and use as medicaments, in particular for the treatment of malignant and other disorders based on pathological cell proliferations.

REFERENCES:
patent: 5424311 (1995-06-01), Billhardt-Troughton et al.
patent: 50-053394 (1975-05-01), None
patent: 2006137723 (2006-06-01), None
patent: WO 99/17759 (1999-04-01), None
patent: WO 03/024448 (2003-03-01), None
patent: WO/2004/005472 (2004-01-01), None
patent: WO 2004/005472 (2004-01-01), None
patent: WO/2004/030635 (2004-04-01), None
patent: WO/2005/010000 (2005-02-01), None
patent: WO/2005/061519 (2005-02-01), None
patent: WO/2005/056825 (2005-06-01), None
patent: WO/2005/103029 (2005-11-01), None
patent: WO/2005/123698 (2005-12-01), None
patent: WO/2005/123733 (2005-12-01), None
patent: WO/2006/042289 (2006-04-01), None
patent: WO/2006/044823 (2006-04-01), None
patent: WO/2006/059103 (2006-06-01), None
patent: WO/2006/073938 (2006-07-01), None
patent: WO/2006/074147 (2006-07-01), None
patent: WO/2006/076646 (2006-07-01), None
patent: WO/2006/078283 (2006-07-01), None
patent: WO/2006/081178 (2006-08-01), None
patent: WO/2006/081179 (2006-08-01), None
patent: WO/2006/081182 (2006-08-01), None
patent: WO/2006/081264 (2006-08-01), None
patent: WO/2006/081388 (2006-08-01), None
patent: WO/2006/128129 (2006-11-01), None
patent: WO/2006/128172 (2006-11-01), None
Vippagunta et al, “Crystalline Solids” Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Gavezzotti, “Are Crystal Structures Predictable?” Accounts of Chemical Research, vol. 27, pp. 309-314 (1994).
Elliot, Robert D., et al.: The Isomeric Pyridopyrazine from the Reaction of Some Tetraaminopyridines with Pyruvaldehyde and Benzil. In: Isomeric Pyridophyrazines, vol. 33, No. 6, Jun. 1968, 2393-2397.
Temple, Carroll, Rener, Gregory A.: Potential Antimitotic Agents. Synthesis of Some Ethyl Benzopyrazin-7-ylcarbamates, Ethyl Pyrido[3,4-b]pyrazin-7-ylcarbamates, and Ethyl Pyrido[3,4-e]-as-triazin-7-ylcarbamates; J. Med. Chem. 1990, 33, 3044-3050.
Kaye, I. A., Some substituted pyrido(2,3)pyrazines, J. Med. Chem. Bd. 7, 1964, Seiten 240-241.

Affiliated with

Also associated with

Rating

Pyridopyrazines and the use thereof as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridopyrazines and the use thereof as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridopyrazines and the use thereof as kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2800545